Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cencora, Inc. (COR : NYSE)
 
 • Company Description   
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

Number of Employees: 51,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $360.83 Daily Weekly Monthly
20 Day Moving Average: 1,365,793 shares
Shares Outstanding: 194.53 (millions)
Market Capitalization: $70,192.51 (millions)
Beta: 0.68
52 Week High: $377.54
52 Week Low: $237.71
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.69% 3.23%
12 Week -1.33% -4.69%
Year To Date 6.83% 6.98%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 West First Avenue
-
Conshohocken,PA 19428
USA		 ph: 610-727-7000
fax: 800-640-5221		 investorrelations@cencora.com http://www.cencora.com
 
 • General Corporate Information   
Officers
Robert P. Mauch - Chief Executive Officer;President and Director
D. Mark Durcan - Chairman and Director
James F. Cleary - Executive Vice President and Chief Financial Offic
Lazarus Krikorian - Senior Vice President and Chief Accounting Officer
Werner Baumann - Director

Peer Information
Cencora, Inc. (CHCR)
Cencora, Inc. (ESRX)
Cencora, Inc. (MYDP)
Cencora, Inc. (COR)
Cencora, Inc. (GBCS)
Cencora, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03073E105
SIC: 5122
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/06/26
Share - Related Items
Shares Outstanding: 194.53
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.68
Market Capitalization: $70,192.51 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.67%
Current Fiscal Quarter EPS Consensus Estimate: $4.83 Indicated Annual Dividend: $2.40
Current Fiscal Year EPS Consensus Estimate: $17.59 Payout Ratio: 0.15
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: -0.02
Estmated Long-Term EPS Growth Rate: 12.35% Last Dividend Paid: 02/13/2026 - $0.60
Next EPS Report Date: 05/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.51
Trailing 12 Months: 22.08
PEG Ratio: 1.66
Price Ratios
Price/Book: 33.40
Price/Cash Flow: 16.70
Price / Sales: 0.22
EPS Growth
vs. Year Ago Period: 9.38%
vs. Previous Quarter: 6.25%
Sales Growth
vs. Year Ago Period: 5.45%
vs. Previous Quarter: 2.63%
ROE
12/31/25 - 176.54
09/30/25 - 227.15
06/30/25 - 267.36
ROA
12/31/25 - 4.25
09/30/25 - 4.30
06/30/25 - 4.31
Current Ratio
12/31/25 - 0.92
09/30/25 - 0.90
06/30/25 - 0.90
Quick Ratio
12/31/25 - 0.51
09/30/25 - 0.55
06/30/25 - 0.53
Operating Margin
12/31/25 - 0.98
09/30/25 - 0.97
06/30/25 - 0.96
Net Margin
12/31/25 - 0.50
09/30/25 - 0.48
06/30/25 - 0.60
Pre-Tax Margin
12/31/25 - 0.72
09/30/25 - 0.70
06/30/25 - 0.81
Book Value
12/31/25 - 10.80
09/30/25 - 9.01
06/30/25 - 11.40
Inventory Turnover
12/31/25 - 15.00
09/30/25 - 15.47
06/30/25 - 15.55
Debt-to-Equity
12/31/25 - 3.62
09/30/25 - 4.32
06/30/25 - 3.64
Debt-to-Capital
12/31/25 - 78.34
09/30/25 - 81.19
06/30/25 - 78.45
 

Powered by Zacks Investment Research ©